Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pleural Effusion I: Introduction01:25

Pleural Effusion I: Introduction

6.3K
Pleural effusion is an abnormal fluid accumulation in the pleural cavity, a narrow space between the lungs and the chest wall. It is not a disease per se but rather a symptom or indication of an underlying disease. In normal circumstances, this space contains a small amount of fluid (5 to 15 mL), a lubricant facilitating the non-frictional movement of the pleural surfaces.
There are two main types of pleural effusion: transudative and exudative. They are differentiated using Light's...
6.3K
Pleural Effusion II: Symptoms and Management01:28

Pleural Effusion II: Symptoms and Management

1.4K
Pleural Effusion Overview
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
1.4K
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

2.5K
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
2.5K
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

1.8K
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
1.8K
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

1.7K
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
1.7K
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

828
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
828

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Correction: Differences in the peripheral blood immune landscape between early-onset and late-onset colorectal cancer.

Frontiers in immunology·2026
Same author

Respiratory alterations in patients with amyotrophic lateral sclerosis.

Medicina clinica·2026
Same author

Saline lavage alone prolongs drainage compared with intrapleural enzyme therapy in pleural infection: the SCOPE randomised controlled trial.

The European respiratory journal·2026
Same author

Paradigm shift in the diagnosis of tuberculous pleural effusion: impact of epidemiology.

Journal of thoracic disease·2026
Same author

Differences in the peripheral blood immune landscape between early-onset and late-onset colorectal cancer.

Frontiers in immunology·2025
Same author

Use of artificial humidification during non-invasive mechanical ventilation in patients with acute respiratory failure: a narrative review.

Journal of thoracic disease·2025
Same journal

Advances in Sarcoidosis.

Archivos de bronconeumologia·2026
Same journal

Spanish Clinical Practice Guidelines for the Diagnosis and Management of Alpha-1 Antitrypsin Deficiency: 2026 Update.

Archivos de bronconeumologia·2026
Same journal

Thoracic Sympathectomy for Harlequin Syndrome.

Archivos de bronconeumologia·2026
Same journal

Prognostic Significance of Electrocardiographic Findings in Hemodynamically Stable Patients With Acute Pulmonary Embolism: Insights From the RIETE Registry.

Archivos de bronconeumologia·2026
Same journal

Endothelial and Angiogenic Biomarkers in Obstructive Sleep Apnea: Longitudinal Associations With Continuous Positive Airway Pressure.

Archivos de bronconeumologia·2026
Same journal

Robotic Resection of Ectopic Paratracheal Thymoma: A Case Report.

Archivos de bronconeumologia·2026
See all related articles

Related Experiment Video

Updated: May 1, 2026

Local Anesthetic Thoracoscopy for Undiagnosed Pleural Effusion
03:22

Local Anesthetic Thoracoscopy for Undiagnosed Pleural Effusion

Published on: November 10, 2023

2.3K

Tuberculous pleural effusion.

Lucía Ferreiro1, Esther San José2, Luis Valdés3

  • 1Servicio de Neumología, Complejo Hospitalario Clínico-Universitario de Santiago, Santiago de Compostela, La Coruña, España.

Archivos De Bronconeumologia
|April 12, 2014
PubMed
Summary
This summary is machine-generated.

Tuberculous pleural effusion (TBPE) is a common extrapulmonary tuberculosis form in Spain, primarily affecting men aged 15-44. Diagnosis can be challenging, but adenosine deaminase and lymphocyte percentage show promise as biomarkers.

Keywords:
Adenosina desaminasaAdenosine deaminaseDerrame pleuralDiagnosisDiagnósticoEpidemiologyEpidemiologíaPleural effusionTratamientoTreatmentTuberculosis

More Related Videos

A Retrospective Study on Endoscopic Surgery for the Treatment of Paravertebral Abscess in Spinal Tuberculosis Patients
03:47

A Retrospective Study on Endoscopic Surgery for the Treatment of Paravertebral Abscess in Spinal Tuberculosis Patients

Published on: October 25, 2024

823
Point-of-Care Lung Ultrasound in Adults: Image Acquisition
09:17

Point-of-Care Lung Ultrasound in Adults: Image Acquisition

Published on: March 3, 2023

9.3K

Related Experiment Videos

Last Updated: May 1, 2026

Local Anesthetic Thoracoscopy for Undiagnosed Pleural Effusion
03:22

Local Anesthetic Thoracoscopy for Undiagnosed Pleural Effusion

Published on: November 10, 2023

2.3K
A Retrospective Study on Endoscopic Surgery for the Treatment of Paravertebral Abscess in Spinal Tuberculosis Patients
03:47

A Retrospective Study on Endoscopic Surgery for the Treatment of Paravertebral Abscess in Spinal Tuberculosis Patients

Published on: October 25, 2024

823
Point-of-Care Lung Ultrasound in Adults: Image Acquisition
09:17

Point-of-Care Lung Ultrasound in Adults: Image Acquisition

Published on: March 3, 2023

9.3K

Area of Science:

  • Pulmonology
  • Infectious Diseases
  • Epidemiology

Background:

  • Tuberculous pleural effusion (TBPE) is the most common extrapulmonary tuberculosis manifestation in Spain.
  • Despite a declining incidence, TBPE consistently represents 14.3%-19.3% of all tuberculosis cases.
  • It predominantly affects men, individuals aged 15-44, and those with human immunodeficiency virus.

Purpose of the Study:

  • To review the epidemiology, pathogenesis, diagnosis, and treatment of tuberculous pleural effusion.
  • To highlight diagnostic challenges and potential biomarker utility.
  • To inform clinical management strategies for TBPE.

Main Methods:

  • Review of existing literature on tuberculous pleural effusion in Spain.
  • Analysis of epidemiological data, including incidence, demographics, and risk factors.
  • Discussion of diagnostic criteria, biomarker performance, and treatment guidelines.

Main Results:

  • TBPE is characterized by unilateral exudative effusion, often right-sided, with a negative tuberculin test in one-third of cases.
  • Adenosine deaminase and lymphocyte percentage in pleural fluid show potential for improved diagnostic accuracy.
  • Standard tuberculosis treatment is effective; corticosteroids are not recommended, and chest drainage can alleviate symptoms in large effusions.

Conclusions:

  • Accurate diagnosis of TBPE can be challenging, necessitating the use of pleural fluid biomarkers.
  • The combination of adenosine deaminase and lymphocyte percentage may enhance diagnostic capabilities.
  • Current treatment protocols for TB are effective, with supportive measures like chest drainage beneficial for symptom management.